Glycobiology, an emerging field of science, combines the disciplines of both carbohydrate biochemistry and molecular biology to study and understand the structure, biosynthesis and biological function of glycans. Research in the Glycobiology Group at NRC-IBS is aimed at development of carbohydrate-based therapeutics for infectious and neurodegenerative diseases. Research activities also include the characterization and development of carbohydrate processing enzymes for therapeutic and industrial applications. The Group develops and applies core technologies for molecular analyses of carbohydrates, along with genomics and proteomics support to identify the biological function of carbohydrates. Research activities support projects in the Immunobiology and Neurobiology Programs.
The Glycobiology Group comprises five distinct groups:
Glycoanalysis,
Genomics & Proteomics,
Glycosidases,
Eukaryotic Glycobiology,
Glycosyltranferases and Neuroglycomics